Lilly’s competitor Novo Nordisk is running two large trials of the obesity drug Wegovy in Alzheimer ... released an eyebrow-raising Super Bowl commercial saying the weight loss industry ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

The biotech has named Jamie Coleman its chief commercial officer ... as U.S. brand leader first for Trulicity and then for Lilly’s obesity portfolio. In her final two years there, beginning ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

We also increased our commercial investment ... became the market leader in the anti-obesity market as measured by new prescriptions. As shown in the Eli Lilly 11, we combine U.S. Incretin Analogs ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

LONDON/COPENHAGEN (Reuters) -Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

1 Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their ... Ms. Walker will collaborate with Lilly on certain digital commercial activities.